TY - JOUR
T1 - NeuroChat with Dr. Karen Gregory
AU - Lindsley, Craig W.
AU - Gregory, Karen J.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/5/20
Y1 - 2020/5/20
N2 - The NeuroChat series continues with a great Q&A with Dr. Karen Gregory from Monash University. Karen is an outstanding, world-leading neuropharmacologist and has published many seminal papers on mGlu receptors and allosteric modulation of GPCRs. After a postdoc in the United States at the VCNDD, Karen returned home as an Australian Research Council Future Fellow, level C Senior Research Fellow, equivalent to Associate Professor within the U.S. system. Never one to be idle, Karen co-leads the Endocrine and Neuropharmacology lab in the Drug Discovery Biology theme at Monash Institute of Pharmaceutical Sciences, and was recently appointed as the Therapeutic Program Area (Neuroscience) Coordinator to enhance multidisciplinary research and tackle the “big” challenges in neuroscience drug discovery. Karen brings unique insight of great value in the Q&A—I invite you to read the discussion below.
AB - The NeuroChat series continues with a great Q&A with Dr. Karen Gregory from Monash University. Karen is an outstanding, world-leading neuropharmacologist and has published many seminal papers on mGlu receptors and allosteric modulation of GPCRs. After a postdoc in the United States at the VCNDD, Karen returned home as an Australian Research Council Future Fellow, level C Senior Research Fellow, equivalent to Associate Professor within the U.S. system. Never one to be idle, Karen co-leads the Endocrine and Neuropharmacology lab in the Drug Discovery Biology theme at Monash Institute of Pharmaceutical Sciences, and was recently appointed as the Therapeutic Program Area (Neuroscience) Coordinator to enhance multidisciplinary research and tackle the “big” challenges in neuroscience drug discovery. Karen brings unique insight of great value in the Q&A—I invite you to read the discussion below.
UR - http://www.scopus.com/inward/record.url?scp=85084962389&partnerID=8YFLogxK
U2 - 10.1021/acschemneuro.0c00183
DO - 10.1021/acschemneuro.0c00183
M3 - Editorial
C2 - 32429671
AN - SCOPUS:85084962389
SN - 1948-7193
VL - 11
SP - 1373
EP - 1375
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
IS - 10
ER -